scispace - formally typeset
S

Shingo Nakaoka

Researcher at Nara Medical University

Publications -  19
Citations -  376

Shingo Nakaoka is an academic researcher from Nara Medical University. The author has contributed to research in topics: Prostate & Thyroid. The author has an hindex of 9, co-authored 19 publications receiving 373 citations.

Papers
More filters
Journal ArticleDOI

Immunohistochemical analysis of midkine expression in human prostate carcinoma.

TL;DR: In sections of whole prostate, MK showed variable expression through tumorous sections, probably in reflection of heterogeneous cell populations, which demonstrates the possible value of MK as a marker for early and latent disease, as well as for more advanced clinical stages of prostate cancer.
Journal ArticleDOI

Expression of nm23-H1 and nm23-H2 proteins in prostate carcinoma.

TL;DR: The data suggest that the nm23/NDP kinase may play a role in suppressing the expression of malignant potential in prostate carcinomas.
Journal ArticleDOI

Immunohistochemical Analysis of Estrogen Receptors in 313 Paraffin Section Cases of Human Thyroid Tissue

TL;DR: It was suggested that ER expression may be related to prognosis and tumor growth at early stage and the observed sex differences regarding thyroid tumor incidence may reflect the higher estrogen serum content in females.
Journal ArticleDOI

Immunohistochemical Evaluation of Estrogen Receptor Status in Benign Prostatic Hypertrophy and in Prostate Carcinoma and the Relationship to Efficacy of Endocrine Therapy

TL;DR: The levels of estrogen receptors in human benign prostatic hypertrophy and in various pathological classifications of prostate carcinoma were assessed and the prognosis for effective endocrine therapy was poor in cases where tissues demonstrated low or negative receptor levels.
Journal ArticleDOI

Relationships between serum thyroid stimulating hormone levels and development of thyroid tumors in rats treated with N-bis-(2-hydroxypropyl)nitrosamine.

TL;DR: A sex difference in DHPN induction of thyroid tumor was shown for Wistar rats opposite to that reported to exist in humans, however, no clear relationship between dose of DHPN or incidence of thyroid tumors and serum TSH concentration was evident at the end of the experiment.